0001437749-24-022025.txt : 20240702
0001437749-24-022025.hdr.sgml : 20240702
20240702181226
ACCESSION NUMBER: 0001437749-24-022025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240630
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cittadine Andrew
CENTRAL INDEX KEY: 0001863624
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 241097524
MAIL ADDRESS:
STREET 1: C/O 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-06-30
0001645469
Monopar Therapeutics
MNPR
0001863624
Cittadine Andrew
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
1
Chief Operating Officer
0
Common Stock
2024-06-30
4
M
0
8952
A
195084
D
Common Stock
2024-06-30
4
F
0
2019
0.731
D
193065
D
Restricted Stock Units
2024-06-30
4
M
0
8952
0
D
Common Stock
8952
73271
D
Represents shares acquired on vesting and settlement of restricted stock units.
Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Karthik Radhakrishnan ,Attorney-in-fact
2024-07-02